» Articles » PMID: 10625271

Improving the Quality of the Cannabis Debate: Defining the Different Domains

Overview
Journal BMJ
Specialty General Medicine
Date 2000 Jan 22
PMID 10625271
Citations 13
Authors
Affiliations
Soon will be listed here.
Citing Articles

The Cardiovascular Effects of Marijuana: Are the Potential Adverse Effects Worth the High?.

Subramaniam V, Menezes A, DeSchutter A, Lavie C Mo Med. 2019; 116(2):146-153.

PMID: 31040502 PMC: 6461323.


Time to acknowledge the mixed effects of cannabis on health: a summary and critical review of the NASEM 2017 report on the health effects of cannabis and cannabinoids.

Cousijn J, Nunez A, Filbey F Addiction. 2017; 113(5):958-966.

PMID: 29271031 PMC: 9520128. DOI: 10.1111/add.14084.


Cannabis Use in Adolescence and Young Adulthood: A Review of Findings from the Victorian Adolescent Health Cohort Study.

Coffey C, Patton G Can J Psychiatry. 2016; 61(6):318-27.

PMID: 27254840 PMC: 4872246. DOI: 10.1177/0706743716645289.


Prevalence of cannabis residues in psychiatric patients: a case study of two mental health referral hospitals in Uganda.

Awuzu E, Kaye E, Vudriko P Subst Abuse. 2014; 8:1-5.

PMID: 24453492 PMC: 3891754. DOI: 10.4137/SART.S13254.


Typologies of cannabis users and associated characteristics relevant for public health: a latent class analysis of data from a nationally representative Canadian adult survey.

Fischer B, Rehm J, Irving H, Ialomiteanu A, Fallu J, Patra J Int J Methods Psychiatr Res. 2010; 19(2):110-24.

PMID: 20506447 PMC: 6878279. DOI: 10.1002/mpr.307.


References
1.
Hall W . Cannabis use and psychosis. Drug Alcohol Rev. 2005; 17(4):433-44. DOI: 10.1080/09595239800187271. View

2.
Donnelly N, Hall W, Christie P . The effects of partial decriminalisation on cannabis use in South Australia, 1985 to 1993. Aust J Public Health. 1995; 19(3):281-7. DOI: 10.1111/j.1753-6405.1995.tb00444.x. View

3.
. Consensus report. Drug concentrations and driving impairment. Consensus Development Panel. JAMA. 1985; 254(18):2618-21. View

4.
Schneider U, Leweke F, Emrich H . Cannabinoid/anandamide system and schizophrenia: is there evidence for association?. Pharmacopsychiatry. 1998; 31 Suppl 2:110-3. DOI: 10.1055/s-2007-979355. View

5.
Linszen D, Dingemans P, Lenior M . Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry. 1994; 51(4):273-9. DOI: 10.1001/archpsyc.1994.03950040017002. View